JMJD3 mediated senescence is required to overcome stress induced hematopoietic defects.
Yuichiro Nakata, Takeshi Ueda, Yasuyuki Sera, Miho Koizumi, Katsutoshi Imamura, Akinori Kanai, Kenichiro Ikeda, Norimasa Yamasaki, Akiko Nagamachi, Kohei Kobatake, Masataka Taguchi, Yusuke Sotomaru, Tatsuo Ichinohe, Zen-ichiro Honda, Takuro Nakamura, , Hiroaki Honda
This study shows JMJD3 promotes senescence in HSPCs to overcome stress-induced hematopoietic defects, with implications for aging and cancer therapies.
EMBO Reports · Jun 25, 2025Peer-reviewedCell Biology